FDA joins Europe in probing rare blood clots after Johnson & Johnson's COVID-19 vaccine

Drug regulators in Europe last week flagged rare but “serious” cases of blood clots in people who had received Johnson & Johnson’s COVID-19 vaccine. But it’s not just European regulators taking a close look at the shot’s safety profile—the FDA is, too.